Patent | Date |
---|
Imidazopyridazines as Akt kinase inhibitors Grant 9,604,989 - Barfacker , et al. March 28, 2 | 2017-03-28 |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors Grant 9,340,528 - Bader , et al. May 17, 2 | 2016-05-17 |
Substituted imidazopyrazines as Akt kinase inhibitors Grant 9,260,435 - Barfacker , et al. February 16, 2 | 2016-02-16 |
Imidazopyridazines As Akt Kinase Inhibitors App 20150368250 - BARFACKER; Lars ;   et al. | 2015-12-24 |
Imidazopyridazines as Akt kinase inhibitors Grant 9,206,185 - Barfacker , et al. December 8, 2 | 2015-12-08 |
Substituted imidazo[1,2-a]pyrimidines and --pyridines Grant 8,975,265 - Ince , et al. March 10, 2 | 2015-03-10 |
Fused pyrimidines Grant 8,957,064 - Vennemann , et al. February 17, 2 | 2015-02-17 |
Substituted Imidazopyrazines As Akt Kinase Inhibitors App 20150005309 - Barfacker; Lars ;   et al. | 2015-01-01 |
Imidazopyridazines As Akt Kinase Inhibitors App 20140113901 - Barfacker; Lars ;   et al. | 2014-04-24 |
Fused Pyrimidines App 20130317002 - Vennemann; Matthias ;   et al. | 2013-11-28 |
Fused Pyrimidines App 20130310362 - Vennemann; Matthias ;   et al. | 2013-11-21 |
Substituted Imidazo[1,2-a]pyrimidines and -pyridines App 20130190332 - Ince; Stuart ;   et al. | 2013-07-25 |
Bicyclic Pyrimidines App 20130184273 - Ince; Stuart ;   et al. | 2013-07-18 |
Substituted Aminoquinoxalines As Tyrosine Threonine Kinase Inhibitors App 20120263708 - Bader; Benjamin ;   et al. | 2012-10-18 |
Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Grant 7,906,533 - Bohlmann , et al. March 15, 2 | 2011-03-15 |
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Grant 7,902,229 - Bohlmann , et al. March 8, 2 | 2011-03-08 |
Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same Grant 7,846,928 - Hartung , et al. December 7, 2 | 2010-12-07 |
Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same Grant 7,825,114 - Hartung , et al. November 2, 2 | 2010-11-02 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines Grant 7,517,894 - Huth , et al. April 14, 2 | 2009-04-14 |
Substituted Aminopyrazolopyridines And Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods Of Preparing Same And Uses Of Same App 20090018129 - Hartung; Ingo ;   et al. | 2009-01-15 |
Substituted Sulfonamido-macrocycles As Tie2 Inhibitors And Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods Of Preparing Same And Uses Of Same App 20090005373 - Hartung; Ingo ;   et al. | 2009-01-01 |
Substituted Pyrazolopyridines And Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods Of Preparing Same And Uses Of Same App 20080058326 - Hartung; Ingo ;   et al. | 2008-03-06 |
Pyrazolopyrimidines And Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods Of Preparing Same And Uses Of Same App 20080039455 - Ince; Stuart ;   et al. | 2008-02-14 |
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones App 20070135489 - Huth; Andreas ;   et al. | 2007-06-14 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones Grant 7,202,260 - Huth , et al. April 10, 2 | 2007-04-10 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines App 20070015794 - Huth; Andreas ;   et al. | 2007-01-18 |
Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors App 20060160861 - Bohlmann; Rolf ;   et al. | 2006-07-20 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines App 20050054654 - Huth, Andreas ;   et al. | 2005-03-10 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones App 20050049281 - Huth, Andreas ;   et al. | 2005-03-03 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines App 20040147535 - Huth, Andreas ;   et al. | 2004-07-29 |
Selected anthranilaminde pyridinamides and their use as pharmaceutical agents App 20040039019 - Huth, Andreas ;   et al. | 2004-02-26 |